Imatinib Mesylate — A New Oral Targeted Therapy
D. G. Savage
and
K. H. Antman
- 28 Feb, 2002
This article requires a subscription.
Login via Athens or your institution
Already a print subscriber? Activate your online access
Not a Subscriber?
